Commission Implementing Regulation (EU) 2026/104 of 8 December 2025 amending Implementing Regulation (EU) 2023/1200 as regards administrative and minor changes to the Union authorisation of the biocidal product family Airedale PAA product family

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 50(2) thereof,

Whereas:

(1) On 21 June 2023, Commission Implementing Regulation (EU) 2023/1200 (2) granted a Union authorisation, under number EU-0028970-0000, to Rigest Trading (Ireland) Limited for the making available on the market and use of the biocidal product family ‘Airedale PAA product family’. The Annex to that Implementing Regulation provides the summary of product characteristics for that biocidal product family.

(2) On 10 June 2024, 20 January 2025 and 22 May 2025, Rigest Trading (Ireland) Limited submitted to the European Chemicals Agency (‘the Agency’), in accordance with Article 11(1) of Commission Implementing Regulation (EU) No 354/2013 (3), notifications of administrative changes to the Union authorisation for the biocidal product family ‘Airedale PAA product family’, as referred to in Title 1 of the Annex to that Regulation. The notifications were recorded in the Register for Biocidal Products (‘the Register’) under case numbers BC-VD095755-21, BC-BW102483-30 and BC-MN106033-46. The notified proposed changes to that authorisation concern the addition of trade names for the biocidal product family.

(3) On 8 November 2024, Rigest Trading (Ireland) Limited submitted to the Agency, in accordance with Article 12(1) of Implementing Regulation (EU) No 354/2013, an application for minor changes to the Union authorisation for the biocidal product family ‘Airedale PAA product family’, as referred to in Title 2 of the Annex to that Regulation. The application was recorded in the Register under case number BC-JD101082-71. The proposed changes to that authorisation concern the splitting of two meta-SPCs, the related extension of the shelf life and a reduction in contact time and in-use concentration.

(4) On 19 July 2024, 29 January 2025 and 14 July 2025, the Agency submitted to the Commission, in accordance with Article 11(3) of Implementing Regulation (EU) No 354/2013, opinions (4) on the notified administrative changes to the Union authorisation for the biocidal product family ‘Airedale PAA product family’, together with a revised summary of the biocidal product characteristics. In the opinions, the Agency concludes that the proposed changes are administrative changes as referred to in Article 50(3), point (a), of Regulation (EU) No 528/2012 and as specified in Title 1, Section 1, of the Annex to Implementing Regulation (EU) No 354/2013, and that, after the implementation of the changes, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met.

(5) On 7 May 2025, the Agency submitted, in accordance with Article 12(4) of Implementing Regulation (EU) No 354/2013, an opinion (5) on the applied minor changes to the Union authorisation for the biocidal product family ‘Airedale PAA product family’ together with a revised summary of the biocidal product characteristics and a revised assessment report. The opinion concludes that the proposed changes are minor changes as referred to in Article 50(3), point (b), of Regulation (EU) No 528/2012 and as specified in Title 2 of the Annex to Implementing Regulation (EU) No 354/2013, and that after the implementation of the changes, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met.

(6) On 14 July 2025, the Agency transmitted to the Commission the revised summary of the biocidal product characteristics of the Union authorisation for the biocidal product family ‘Airedale PAA product family’ in all official languages of the Union, covering all the administrative changes and minor changes applied for, in accordance with Article 11(6) and Article 12(6) of Implementing Regulation (EU) No 354/2013.

(7) The Commission concurs with the opinions of the Agency and therefore considers it appropriate to amend the Union authorisation for the biocidal product family ‘Airedale PAA product family’ to introduce the administrative and minor changes requested by Rigest Trading (Ireland) Limited.

(8) Except for the amendments regarding the administrative and minor changes, all other information included in the summary of the biocidal product characteristics of ‘Airedale PAA product family’ as set out in the Annex to Implementing Regulation (EU) 2023/1200 remains unchanged.

(9) In order to enhance clarity and to ease the access of users and interested parties to the consolidated version of the summary of the biocidal product characteristics which is to be published by the Agency, the Annex to Implementing Regulation (EU) 2023/1200 should be replaced in its entirety. Due to a change in the format used for the generation of the summary of biocidal product characteristics in the Register in February 2024, the summary of biocidal product characteristics in that Annex should also include some minor editorial and layout changes.

(10) Implementing Regulation (EU) 2023/1200 should therefore be amended accordingly,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Implementing Regulation (EU) 2023/1200 is replaced by the text in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 8 December 2025.

For the Commission The President Ursula VON DER LEYEN

(1) OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.

(2) Commission Implementing Regulation (EU) 2023/1200 of 21 June 2023 granting a Union authorisation for the biocidal product family ‘Airedale PAA product family’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 159, 22.6.2023, p. 3, ELI http://data.europa.eu/eli/reg_impl/2023/1200/oj).

(3) Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p.4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj).

(4) ECHA Opinions No UAD-C-1752734-32-00/F of 19 July 2024, No UAD-C-1795075-20-00/F of 29 January 2025 and No UAD-C-1839361-19-00/F of 14 July 2025 on the administrative changes of the Union authorisation of the biocidal product family ‘Airedale PAA product family’, https://echa.europa.eu/opinions-on-union-authorisation.

(5) Biocidal Products Committee (BPC) opinion on the minor change to the Union authorisation of the biocidal product family ‘Airedale PAA product family’ of 7 May 2025, ECHA/BPC/458/2025 https://echa.europa.eu/opinions-on-union-authorisation.